Peptide Decoding
New?New to peptides?Start here →
Decoding

Teriparatide (Forteo)_Dosage, benefits & legal status

Also known as Forteo, Teriparatide, PTH 1-34, parathyroid hormone 1-34, Bonsity

Published August 14, 2026

The bone drug that builds new bone instead of just slowing the loss.

Bone strengthParathyroid hormone fragmentFDA-approved
Dose20 mcg per day
FrequencyDaily
RouteUnder the skin (subcutaneous)
StatusFDA-approved
CycledDaily, usually for up to two years, then a different drug afterward

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Teriparatide (Forteo)?

Plain language first. The technical label stays, but it never stands alone.

Overview

It is the drug used when bones are weak enough that slowing the damage is not enough.

The technical version

Teriparatide is the working part of parathyroid hormone, the hormone that manages calcium in your body. Most osteoporosis drugs slow bone from breaking down. This one does the opposite job: it tells the body to build new bone.

What it's used for

A daily injection for osteoporosis, taken by people at high risk of breaking a bone, to build bone back up.

02

How does Teriparatide (Forteo) work?

What it does in the body, and where.

Bone is constantly torn down and rebuilt. Parathyroid hormone can push either way, and the difference is timing: a short daily spike builds bone, while a constant high level takes it away.

  1. 01
    It is the active piece of parathyroid hormone
    The first 34 amino acids of the natural hormone, which is the part that binds the receptor.
  2. 02
    A short daily spike wakes up the bone-building cells
    Osteoblasts are the cells that lay down new bone. A brief signal encourages more of them to work and fewer to die off.
  3. 03
    It is out of the body within about three hours
    That is the point. The spike has to end. A level that stays high does the opposite and pulls calcium out of bone.
  4. 04
    Blood calcium rises briefly after each dose
    It peaks around 4 to 6 hours after injecting and is back to normal within a day. This is expected, and it is why calcium is checked.
Where it acts
Joint

Where this compound is thought to act.

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Osteoporosis in women after menopause who are at high risk of fractureFDA-approved
  • Building bone in men with osteoporosisFDA-approved
  • Osteoporosis caused by long-term steroid medicationFDA-approved
  • Helping stubborn fractures heal, which doctors sometimes try off-labelEarly research

The published record

Research index

5,025

Papers and trials about Teriparatide (Forteo)

363 papers tagged human · 195 not reviews or lab · 60 clinical trial publications

196 registered trials · 32 with posted results

Furthest stage reached: Approved in the US

Compare this against the whole library →

In animals102
In the lab12
Reviews94
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. 499 papers and 100 trials indexed in detail.

Teriparatide (Forteo) vial rendering
Compound field notes

At a glance

Four things to know about Teriparatide (Forteo)

01

Evidence

FDA-approved

02

Category

Healing and recovery

03

Common vial

Varies

04

Half-life

About 1 hour

04

How much, and do you cycle it?

The range, and whether you take breaks.

20 mcg per day, daily. Daily, usually for up to two years, then a different drug afterward Clinical use

The FDA removed the hard two-year limit in 2020, but the usual pattern is still a course of about two years followed by a drug that holds the new bone in place. Bone gained is lost again if nothing follows.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

About 1 hourFDA label

About 1 hour by subcutaneous injection, and about 5 minutes intravenously. The longer subcutaneous figure reflects the time absorption takes rather than slower clearance. Serum levels return to baseline within 3 to 4 hours, which is a different measurement and is where the 3 hour figure came from.

Source: Forteo label section 12.3, DailyMed setid aae667c5-381f-4f92-93df-2ed6158d07b0

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Enter the amount printed on your label.
What you paid per vial
$
Used for cost per dose only.
Your dose (mcg)
Commonly referenced dose: 20 mcgFDA label

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW0 / 100 units
What it costs

We track Teriparatide (Forteo) at 1 vendor, and publishes its price.

1 listing, last read Oct 10, 2026. Shipping and card fees are not included.

See all 1 listings →
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Teriparatide (Forteo) keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.
Handling note

This is a ready-to-use pen with nothing to mix. One pen holds 600 micrograms in 2.4 mL, which is 28 daily doses, and it must stay in the fridge the whole time, including once you start using it. Take the first dose sitting or lying down, because it can make you dizzy. The pen has been reported to release its entire contents by mistake, which is forty times a normal dose, so follow the device instructions exactly.

Solubility, computed: 32% charged residues, 38% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • Known allergy to teriparatide
  • High blood calcium already
  • Bone cancer, or cancer that has spread to bone
  • Paget disease of bone, or unexplained high alkaline phosphatase
  • Past radiation treatment involving the skeleton
  • Pregnancy or breastfeeding

Stop and get help

These are emergencies. Seek care.
  • Fainting, or dizziness that does not settle after the first few doses
  • Signs of high calcium such as constant nausea, vomiting, constipation, or confusion
  • New bone pain in one spot that keeps getting worse
  • Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing

Common effects

Expected, and usually mild.
  • Dizziness or lightheadedness, usually in the first few doses
  • A racing heartbeat shortly after injecting
  • Nausea
  • Leg cramps
  • Injection-site reactions
  • Joint aches

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Teriparatide (Forteo) approved?

And where the numbers on this page come from.

Yes. Teriparatide (Forteo) is FDA approved and available on prescription in the United States.

  • Approval status
    FDA-approved
  • Route
    Under the skin (subcutaneous)
  • Checked
    14 August 2026
  • Dose
    From the drug label. The manufacturer tested this range and a regulator reviewed it.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources

What has happened recently

FDA-approved for osteoporosis. In 2020 the FDA removed both the boxed warning about a bone cancer called osteosarcoma and the two-year limit on how long it could be taken. The warning came from rats given very high doses for most of their lives, and long-term human data did not show the same pattern. Older articles still repeat the two-year rule, and it no longer applies.

Guides for this compound

Sources

Beyond these, 599 records are indexed. Browse the records